ICU Pneumonia Patient Cohort with Lactate Dehydrogenase-to-Albumin Ratio Biomarker

499 ICU patients with pneumonia receiving glucocorticoids from a multicenter cohort study. The dataset likely contains clinical variables used to evaluate the lactate dehydrogenase-to-albumin ratio (LAR) as a predictor for 30-day and 90-day mortality. The analysis was authored by Dandan Han and last updated on 2026-05-05.

Use Cases

• Predicting short-term mortality in ICU patients based on steroid-resilient biomarkers.
• Evaluating the incremental prognostic value of a biomarker when added to established risk scores.
• Training risk stratification models for pneumonia patients receiving glucocorticoid therapy.
• Analyzing dose-response relationships between biomarker levels and mortality outcomes.

Strengths

• Data originates from a multicenter cohort, suggesting multi-site representation.
• The analysis includes 499 patient records.
• The dataset is associated with a detailed secondary analysis using multivariable Cox regression and propensity score matching.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is stored as a PDF (1.6 MB), which may require extraction to access structured data.

Provenance

Source

figshare

Collection Method

Secondary analysis of a multicenter cohort.

Freshness

Last updated 2026-05-05 05:23:48; freshness should be verified.